Clinical Trials on Irritable Bowel Syndrome in Australia
Total 0 results
Nothing found
Sponsors and Collaborators
- ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITRO
- Sublimity Therapeutics Holdco Limited
- Ouctomes Research Consortium, Cleveland Clinic, Ohio, USA
- Daniela Pacella - University of Naples Federico II, Naples
- Hospitales Universitarios Virgen del Rocío
- Centro Universitário Franciscano
- the people hospital of Linzhi
- Åke Wibergs Stiftelse
- The Australia-Israel Scientific Exchange Foundation (AISEF)
- ECMC
- ADOR - Territorial Support Network, Device and Tools for Primary Care Teams
- National Institute of Cardiovascular Diseases, Bangladesh
- Direction Interarmées du Service de Santé des Armées (DIASS) de Cayenne, French Guiana
- IRCCS Istituto Auxologico Italiano, Milano, Italy
- Sahachat Aueyingsak
- AlpinARC
- Dr Philippe METELLUS
- Bassam Abdulkarim
- Glasgow Western Infirmary
- Etan Orgel
- View Full List
Medical Conditions
- Legal History
- Failed Open Reduction Internal Fixation (ORIF) of a Radial Head Fracture
- Interviews
- Hyperprolinemia
- Orthopaedic Disorders
- Eosinophil Blood Count
- Very Long Chain Acyl Coa Dehydrogenase Deficiency
- Pancreaticoduodenectomy
- Initiation of Depo-Provera (DMPA)
- Transitional Cell Carcinoma of Renal Pelvis
- Bladder Cancer TNM Staging Primary Tumor (T) T2B
- Adult Patients Undergoing Surgery That Requires General Anesthesia
- Value-Based Health Insurance
- Degenerative Spondylolisthesis G1
- Implanted With Any Currently (and Any Future) FDA-approved Medtronic ICD or CRT Device
- Patients With Leptomeningeal Disease
- Ability to Swim 100m Independent Freestyle
- Genetic Risk Factor
- Progression to PD-1 Antibody
- Panniculectomy
- View Full List
Drug Interventions
- ATG-008 30 mg, orally, QD, each 4 week (28-day) a cycle
- 6% hetastarch
- 0% N2O
- Omeprazole 20mg
- 5-Fluoro-uracil
- Erythropoietin
- Paliperidone palmitate
- Gefitinib
- Prasugrel
- UFUR and Iressa
- Nimotuzumab
- HBM4003 and Triprilimab
- Mepivacaine
- Injectable Insulin
- Antibiotic treatment
- IV rtPA (intravenous recombinant plasminogen activator)
- Epirubicin hydrochloride
- Metoclopramide + dexamethasone
- ASP8062
- Cefuroxime 750mg oral
- View Full List
CROs by country
- Contract Research Organizations in Burundi
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Ireland
- Contract Research Organizations in Jamaica
- Contract Research Organizations in Japan
- Contract Research Organizations in Malta
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Philippines
- Contract Research Organizations in Poland
- Contract Research Organizations in Portugal
- Contract Research Organizations in Spain
- Contract Research Organizations in Tanzania
- Contract Research Organizations in United Kingdom
- CRO list by country